These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 27900407

  • 1. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG.
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [Abstract] [Full Text] [Related]

  • 2. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG.
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [Abstract] [Full Text] [Related]

  • 3. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
    Tiselius HG, Hallin A, Lindbäck B.
    Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
    [Abstract] [Full Text] [Related]

  • 4. How do stones form? Is unification of theories on stone formation possible?
    Bird VY, Khan SR.
    Arch Esp Urol; 2017 Jan; 70(1):12-27. PubMed ID: 28221139
    [Abstract] [Full Text] [Related]

  • 5. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C.
    Scand J Urol Nephrol Suppl; 1990 Jan; 130():1-83. PubMed ID: 2291093
    [Abstract] [Full Text] [Related]

  • 6. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
    Li S, Macaringue EGJ, Zhou D, Shi P, Tang W, Gong J.
    J Ethnopharmacol; 2022 Feb 10; 284():114733. PubMed ID: 34644589
    [Abstract] [Full Text] [Related]

  • 7. Kidney models of calcium oxalate stone formation.
    Robertson WG.
    Nephron Physiol; 2004 Feb 10; 98(2):p21-30. PubMed ID: 15499211
    [Abstract] [Full Text] [Related]

  • 8. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR, Glenton PA, Backov R, Talham DR.
    Kidney Int; 2002 Dec 10; 62(6):2062-72. PubMed ID: 12427130
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H, Tiselius HG.
    Urol Res; 1997 Dec 10; 25(5):365-72. PubMed ID: 9373919
    [Abstract] [Full Text] [Related]

  • 10. Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
    Tiselius HG, Lindbäck B, Fornander AM, Nilsson MA.
    Urol Res; 2009 Aug 10; 37(4):181-92. PubMed ID: 19444436
    [Abstract] [Full Text] [Related]

  • 11. In situ flow cell platform for examining calcium oxalate and calcium phosphate crystallization on films of basement membrane extract in the presence of urinary 'inhibitors'.
    Kuliasha CA, Rodriguez D, Lovett A, Gower LB.
    CrystEngComm; 2020 Feb 28; 22(8):1448-1458. PubMed ID: 32256199
    [Abstract] [Full Text] [Related]

  • 12. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B.
    Ther Umsch; 2003 Feb 28; 60(2):79-87. PubMed ID: 12649986
    [Abstract] [Full Text] [Related]

  • 13. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A.
    Kidney Int; 1999 Mar 28; 55(3):1041-50. PubMed ID: 10027942
    [Abstract] [Full Text] [Related]

  • 14. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
    Asplin JR, Parks JH, Coe FL.
    Kidney Int; 1997 Dec 28; 52(6):1602-8. PubMed ID: 9407506
    [Abstract] [Full Text] [Related]

  • 15. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO, Schmiedl A, Herrmann U, Fan J, Gottlieb D, Manoharan M, Wipplinger J.
    Urol Res; 1999 Apr 28; 27(2):117-26. PubMed ID: 10424393
    [Abstract] [Full Text] [Related]

  • 16. Magnesium Decreases Urine Supersaturation but Not Calcium Oxalate Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
    Li Q, Krieger NS, Yang L, Asplin J, Bushinsky DA.
    Nephron; 2024 Apr 28; 148(7):480-486. PubMed ID: 38262368
    [Abstract] [Full Text] [Related]

  • 17. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO, Schmiedl A, Wipplinger J.
    Eur J Med Res; 2009 Sep 01; 14(9):378-92. PubMed ID: 19748857
    [Abstract] [Full Text] [Related]

  • 18. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
    O'Kell AL, Lovett AC, Canales BK, Gower LB, Khan SR.
    Urolithiasis; 2019 Aug 01; 47(4):335-346. PubMed ID: 30218116
    [Abstract] [Full Text] [Related]

  • 19. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A, Meschi T, Schianchi T, Allegri F, Novarini A, Borghi L.
    Acta Biomed; 2002 Aug 01; 73(1-2):11-26. PubMed ID: 12233273
    [Abstract] [Full Text] [Related]

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.